Fentanyl Transdermal Patch and Selpercatinib: Interaction Details

Brand names
Fentanyl Transdermal Patch
DuragesicAbstralSubsys +3 more
Selpercatinib
Retevmo
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Fentanyl Transdermal Patch and Selpercatinib interaction:

Share

Share this interaction

Fentanyl Transdermal Patch

Brand names
  • Duragesic
  • Abstral
  • Subsys
  • Ionsys
  • Actiq
  • Fentora

What Happens When You Take Fentanyl Transdermal Patch With Selpercatinib

What can happen when they are taken together (rated Major)

Increased exposure and an increased risk for adverse effects

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Selpercatinib is a weak , so it should not be given together with a CYP3A substrate when even small shifts in the substrate's concentration could cause adverse reactions. A trial of selpercatinib taken with midazolam, a sensitive CYP3A substrate, found that midazolam (0 to inf) rose by 54% and rose by 39%. When using selpercatinib with such a CYP3A substrate cannot be avoided, a lower dose of the substrate may be considered, as appropriate.1

The Fentanyl Transdermal Patch and Selpercatinib Interaction, Explained

Fentanyl patches are a strong pain medicine. Your body breaks fentanyl down mostly using an enzyme called . Selpercatinib (Retevmo) can slow that enzyme a little. That means fentanyl may build up more than expected, which can raise the chance of side effects like heavy sleepiness, slow or shallow breathing, and confusion.

This is based mainly on how the drugs work and on a study with a different drug, so it is a theoretical concern. Still, because fentanyl is so strong, it is taken seriously. Please keep using both as prescribed and talk with your pharmacist or doctor. Your care team can adjust the fentanyl dose if needed and watch you closely.

Mechanism: Selpercatinib is a weak . Fentanyl is a (not a ), so may increase fentanyl exposure, with greater risk of adverse effects including and .

  • Magnitude: Not studied with fentanyl. With midazolam (sensitive CYP3A substrate), selpercatinib increased (0-inf) by 54% and by 39%.
  • Evidence: Theoretical (extrapolated). Onset unspecified.
  • Management: Avoid if possible. If is necessary, consider reducing the fentanyl dose as appropriate, and monitor for sedation and respiratory depression, especially with initiation or dose changes. Transdermal fentanyl has a prolonged depot effect, so effects may persist.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Fentanyl Transdermal Patch and Selpercatinib Interact

The likely mechanism

of -mediated by selpercatinib

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Fentanyl Transdermal Patch and Selpercatinib Interaction

Your care team may choose a different pain plan if possible. If you need both medicines, the fentanyl dose may need to be adjusted and individualized by your care team, and your team may monitor you more closely.

  • Keep using both medicines as prescribed. Do not change or stop either one on your own.
  • Tell your pharmacist and prescriber about every medicine you take, including new ones.
  • Report unusual drowsiness, slow or shallow breathing, or confusion right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Fentanyl Transdermal Patch or Selpercatinib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: RETEVMO oral capsules, tablets, selpercatinib oral capsules, tablets

    A study found that giving selpercatinib together with midazolam (a sensitive ) raised midazolam (0 to inf) by 54% and by 39%.1

Fentanyl Transdermal Patch and Selpercatinib: Common Questions

How serious is the Fentanyl Transdermal Patch and Selpercatinib interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Fentanyl Transdermal Patch and Selpercatinib interaction managed?

Your care team may choose a different pain plan if possible. If you need both medicines, the fentanyl dose may need to be adjusted and individualized by your care team, and your team may monitor you more closely. Keep using both medicines as prescribed. Do not change or stop either one on your own. Tell your pharmacist and prescriber about every medicine you take, including new ones. Report unusua… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Fentanyl Transdermal Patch and Selpercatinib Interaction

Ask in your own words about taking Fentanyl Transdermal Patch and Selpercatinib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: RETEVMO(R) oral capsules, tablets, selpercatinib oral capsules, tablets. Lilly USA LLC (per FDA), Indianapolis, IN, 2024. DailyMed
Was this write-up helpful?

Other Serious Interactions of Fentanyl Transdermal Patch and Selpercatinib

Also serious with Fentanyl Transdermal Patch

Also serious with Selpercatinib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Selpercatinib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.